TherapeuticsMD (TXMD) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2023)
TherapeuticsMD (TXMD) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -45.13% |
| Jun 30, 2023 | -37.33% |
| Mar 31, 2023 | -32.87% |
| Dec 31, 2022 | -29.15% |
| Sep 30, 2022 | 4.22% |
| Jun 30, 2022 | 7.98% |
| Mar 31, 2022 | 16.18% |
| Dec 31, 2021 | 9.75% |
| Sep 30, 2021 | 24.69% |
| Jun 30, 2021 | 29.95% |
| Mar 31, 2021 | 46.92% |
| Dec 31, 2020 | 57.78% |
| Sep 30, 2020 | 103.28% |
| Dec 31, 2019 | 108.73% |
| Jun 30, 2019 | 79.58% |
| Dec 31, 2018 | 50.45% |
| Mar 31, 2018 | 38.38% |
| Dec 31, 2017 | 46.09% |
| Sep 30, 2017 | 36.35% |
| Jun 30, 2017 | 35.12% |